[Federal Register Volume 77, Number 49 (Tuesday, March 13, 2012)]
[Notices]
[Pages 14837-14838]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-5998]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: NRC will convene a meeting of the Advisory Committee on the
Medical Uses of Isotopes (ACMUI) on April 16-17, 2012. A sample of
agenda items to be discussed during the public session includes: (1)
Fundamental concepts in patient advocacy; (2) electronic signatures for
documents that are required to be signed in accordance with U.S.
Nuclear Regulatory Commission (NRC) regulations; (3) medical-related
events from fiscal year 2011; (4) an update on proposed regulatory
changes for Permanent Implant Brachytherapy programs; (5) the status of
the Commission Paper on data collection for Patient Release; (6) a
status update on 10 CFR Part 35 rulemaking; (7) medical use of radium-
223 chloride; (8) an update on strontium breakthrough with rubidium-82
generators from NRC and FDA perspectives; and (9) half-life activity as
a function of solar activity. The agenda is subject to change. The
current agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by emailing Ms. Sophie
Holiday at the contact information below.
Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of
Byproduct Material.
Date and Time for Closed Session: April 16, 2012, from 8 a.m. to
10:45 a.m. This session will be closed so that ACMUI members can
prepare for an upcoming Commission briefing.
Date and Time for Open Sessions: April 16, 2012, from 10:45 a.m. to
5 p.m. and April 17, 2012, from 8 a.m. to 12:30 p.m.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building, Room T2-
[[Page 14838]]
B3, 11545 Rockville Pike, Rockville, Maryland 20852.
Public Participation: Any member of the public who wishes to
participate in the meeting in person or via phone should contact Ms.
Holiday using the information below. The meeting will also be webcast
live: http://www.nrc.gov/public-involve/public-meetings/webcast-live.html.
Contact Information: Sophie J. Holiday, email:
[email protected], telephone: (301) 415-7865.
Conduct of the Meeting
Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Holiday at the contact information listed above.
All submittals must be received by April 9, 2012, and must pertain to
the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript will be available on ACMUI's Web site
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about
May 18, 2012. A meeting summary will be available on ACMUI's Web site
(http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/
) on or about May 29, 2012.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Holiday of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10, U.S. Code of Federal Regulations, Part 7.
Dated: March 7, 2012.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2012-5998 Filed 3-12-12; 8:45 am]
BILLING CODE 7590-01-P